Comprehensive Study Notes on Protein Sorting and Intracellular Transport

Foundations of Protein Localization and Sorting

  • Protein localization is essential for maintaining cellular structure, function, and homeostasis. It ensures proteins perform roles in correct compartments; a protein in the incorrect compartment can be functionally absent or harmful.

  • Sorting preserves biochemical compatibility, membrane topology, and signaling fidelity. Clinical diseases often result from failures in specific trafficking steps.

  • The central logistics problem: Synthesis \rightarrow Recognition of a sorting signal \rightarrow Transport \rightarrow Arrival and Retention.

  • A protein's amino-acid sequence contains the information determining its cellular destination. A normal catalytic domain cannot compensate for delivery to the wrong compartment.

  • Sorting Signals:

    • Signal Sequence: A continuous amino-acid stretch, typically at the N- or C-terminus. It is often cleaved after reaching the destination.

    • Signal Patch: A three-dimensional surface formed after the protein folds, where residues may be distant in the linear sequence but come together in the tertiary structure.

Mechanisms of Intracellular Transport

  • Internal compartments are categorized by topological relationships. Topologically equivalent spaces include the ER lumen, Golgi lumen, lysosomes, and the cell exterior.

  • Gated Transport:

    • Involves selective passage through nuclear pore complexes (NPCs).

    • Occurs between topologically equivalent spaces (cytosol and nucleus).

    • Cargo may remain folded during transport.

    • Example: Transcription factors.

  • Transmembrane Transport:

    • Proteins cross a membrane through a membrane-bound protein translocator.

    • Transports proteins from the cytosol into a space that is topologically distinct.

    • Cargo usually must unfold to snake through the translocator.

    • Examples: Movement into the endoplasmic reticulum (ER) and mitochondria.

  • Vesicular Transport:

    • Membrane-enclosed carriers (vesicles) move cargo between compartments.

    • Cargo does not cross a lipid bilayer; instead, vesicles bud from a donor compartment and fuse with a target compartment.

    • Occurs only between topologically equivalent compartments.

    • Example: ER to Golgi transport.

Gated Transport: Nuclear-Cytoplasmic Logistics

  • Nuclear Pore Complex (NPC):

    • A selective gateway spanning the inner and outer nuclear membranes.

    • Built from nucleoporins; FG-repeat domains form the selective barrier.

    • Passive Diffusion: Small molecules and small proteins diffuse down concentration gradients.

    • Receptor-Mediated Transport: Large cargo requires importins or exportins and specific localization signals.

    • Traffic stats: Up to 500500 macromolecules per second, including histones, DNA polymerase, RNA polymerase, transcription factors, and splicing factors.

  • Nuclear Import Mechanism:

    • The Nuclear Localization Signal (NLS) is exposed on the cargo.

    • Importin binds the cargo; the complex crosses the NPC.

    • Ran-GTP binds the importin, causing the release of the cargo into the nucleus.

    • Directionality is maintained by a gradient: High Ran-GTP in the nucleus and high Ran-GDP in the cytosol.

  • Nuclear Export Mechanism:

    • Nuclear Export Signal (NES) cargo in the nucleus binds a complex of Exportin and Ran-GTP.

    • The complex crosses the NPC to the cytosol.

    • GTP hydrolysis occurs, releasing the cargo.

    • Comparison: Import cargo dissociates when Ran-GTP binds importin, whereas export cargo forms a stable complex with exportin and Ran-GTP inside the nucleus.

  • Clinical Case (Nuclear Localization Defect):

    • In a child with recurrent severe infections, a mutation in a transcription factor prevents nuclear localization.

    • Mechanism: Altered NLS or importin recognition leads to impaired entry; the protein remains in the cytosol and cannot activate immune-response genes.

Mitochondrial Protein Import

  • Mitochondria Structure:

    • Outer membrane: Freely permeable to small molecules.

    • Inner membrane: Contains complexes for electron transport and oxidative phosphorylation.

    • Matrix: Contains citric acid cycle enzymes.

    • Site of ATP production and apoptosis trigger (via cytochrome c release).

  • Targeting Principles:

    • Most mitochondrial proteins are encoded by nuclear genes and translated on free cytosolic ribosomes.

    • Matrix-targeting presequences are typically N-terminal, amphipathic, positively charged, and cleaved after import.

  • Matrix Import Steps:

    • Precursor proteins are kept unfolded by cytosolic chaperones (Hsp70).

    • TOM (Translocator of the Outer Membrane) recognizes the signal and facilitates outer-membrane passage.

    • TIM23 (Translocator of the Inner Membrane) facilitates crossing of the inner membrane.

    • Energy inputs: ATPATP supports chaperone cycles; inner-membrane potential (Δψ\Delta\psi) electrophoretically favors the entry of the positively charged sequence.

    • Matrix Hsp70 pulls the protein into the matrix; the signal is then cleaved.

  • Clinical Case (Mitochondrial Dysfunction):

    • Mutations weakening matrix-targeting presequences affect high-energy tissues first, such as the brain and skeletal muscle.

    • Symptoms include exercise intolerance, neurologic findings, and lactic acidosis due to impaired oxidative phosphorylation.

The Endoplasmic Reticulum (ER) and Secretory Pathway

  • Proteins entering the ER include soluble secretory proteins (hormones, antibodies), lumenal resident proteins, and membrane proteins.

  • Targeting via SRP (Signal Recognition Particle):

    • The ER signal peptide (often a stretch of hydrophobic amino acids preceded by basic residues like arginine) emerges from the ribosome.

    • SRP binds the peptide and ribosome, briefly pausing translation.

    • SRP receptor docks the complex at the ER; the ribosome transfers to a translocon (Sec61 complex).

    • Translation resumes as the growing chain enters the ER (co-translational translocation).

  • Protein Processing and Quality Control:

    • N-linked Glycosylation: A preassembled oligosaccharide is transferred to selected asparagine residues.

    • Folding: Chaperones and disulfide-bond formation assist folding.

    • Quality-Control Checkpoint: Correctly folded proteins exit the ER; misfolded proteins undergo retrotranslocation and ubiquitin-proteasome degradation (ERAD).

    • Unfolded Protein Response (UPR): Activated by persistent stress.

  • Clinical Case (Cystic Fibrosis):

    • Caused by the CFTRΔF508CFTR \Delta F508 mutation.

    • The protein misfolds and is retained by ER quality control, then degraded by ERAD. Even if potentially functional, the protein fails to reach the plasma membrane.

Vesicular Transport: Coats, Rabs, and SNAREs

  • The Vesicle Cycle: Cargo selection \rightarrow Coat assembly \rightarrow Budding and Scission \rightarrow Uncoating \rightarrow Tethering and Docking \rightarrow SNARE-mediated fusion.

  • Coat Proteins defining routes:

    • COPII: Forward (anterograde) route from ER to Golgi.

    • COPI: Retrograde retrieval from Golgi to ER and transport within Golgi.

    • Clathrin: Trans-Golgi to endosomes and plasma membrane to endosomes.

  • Specificity and Fusion:

    • Rab GTPases: Provide compartment identity and guide vesicles to the correct target membrane. Rab-GTP on the vesicle binds tethers on the target membrane.

    • SNARE Proteins: v-SNAREs (vesicle) and t-SNAREs (target) pair specifically to form a trans-SNARE complex. Zippering pulls bilayers together, opening a fusion pore.

Golgi Processing and Lysosomal Sorting

  • Retrieval of Resident Proteins:

    • KDEL: Soluble ER proteins that escape to the Golgi bind KDEL receptors and return via COPI carriers.

    • KKXX: ER membrane proteins recruit COPI for retrograde transport.

  • Golgi Transformations:

    • Organized into cis-, medial-, and trans-Golgi, plus the trans-Golgi network (TGN).

    • Functions: Glycan trimming/addition, O-linked glycosylation, proteolytic processing, and sorting.

    • Medical Application (ABO Blood Groups): Group A (N-acetylgalactosamine added), Group B (galactose added), Group O (inactive transferase leaves H antigen unmodified).

  • Lysosomal Sorting (M6P Pathway):

    • Hydrolases receive a Mannose-6-phosphate (M6P) tag in the Golgi via GlcNAc phosphotransferase.

    • M6P receptors in the TGN bind the cargo; clathrin carriers transport them to endosomes.

    • Low pH in the endosome releases the enzyme; the receptor recycles.

  • Clinical Case (I-cell Disease):

    • Defective GlcNAc phosphotransferase results in no M6P tag.

    • Acid hydrolases are secreted instead of being sent to lysosomes. Diagnostic logic: High plasma levels of lysosomal enzymes.

Endocytosis and Secretion

  • Exocytosis:

    • Constitutive Secretion: Continuous delivery to the plasma membrane.

    • Regulated Secretion: Specialized cells (e.g., insulin in β\beta-cells) store cargo in granules, released following a signal like Ca2+{Ca}^{2+} entry after membrane depolarization.

  • Endocytosis Types:

    • Phagocytosis: Large particles (microbes) taken up by professional phagocytes.

    • Pinocytosis: Continuous uptake of extracellular fluid via clathrin-coated pits.

    • Receptor-Mediated Endocytosis: Selective concentrate of cargo (e.g., LDL).

  • Clinical Case (Familial Hypercholesterolemia):

    • LDL receptor is a single-pass glycoprotein (840840 amino acids).

    • Defects in the LDL receptor or clathrin-mediated uptake lead to high plasma LDL (320mg/dL320\,mg/dL) and premature atherosclerosis.